WO2010131865A3 - Composition antimicrobienne active contre une souche résistante aux antibiotiques - Google Patents

Composition antimicrobienne active contre une souche résistante aux antibiotiques Download PDF

Info

Publication number
WO2010131865A3
WO2010131865A3 PCT/KR2010/002845 KR2010002845W WO2010131865A3 WO 2010131865 A3 WO2010131865 A3 WO 2010131865A3 KR 2010002845 W KR2010002845 W KR 2010002845W WO 2010131865 A3 WO2010131865 A3 WO 2010131865A3
Authority
WO
WIPO (PCT)
Prior art keywords
antibiotic
resistant
antimicrobial composition
resistant strain
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2010/002845
Other languages
English (en)
Korean (ko)
Other versions
WO2010131865A2 (fr
Inventor
김종기
김헌
임수연
이수성
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industry Academic Cooperation Foundation of Chung Ang University
Original Assignee
Industry Academic Cooperation Foundation of Chung Ang University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020090041757A external-priority patent/KR101171871B1/ko
Priority claimed from KR1020090041743A external-priority patent/KR20100122713A/ko
Application filed by Industry Academic Cooperation Foundation of Chung Ang University filed Critical Industry Academic Cooperation Foundation of Chung Ang University
Publication of WO2010131865A2 publication Critical patent/WO2010131865A2/fr
Publication of WO2010131865A3 publication Critical patent/WO2010131865A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une composition antimicrobienne active contre une souche résistante aux antibiotiques, laquelle composition contient, comme ingrédients actifs, un ou plusieurs éléments choisis dans un groupe composé du sulforaphène et du sulforaphane. PLus particulièrement, la présente invention a trait à une composition antimicrobienne qui renferme, en tant qu'ingrédients actifs, un ou plusieurs éléments choisis dans un groupe composé du sulforaphène et du sulforaphane et qui agit sur le staphylocoque résistant à la méthicilline, l'entérocoque résistant à la vancomycine ou le bacille du côlon résistant aux antibiotiques, le pneumobacille, le Salmonella typhimurium et l'Enteroccocus faecalis et analogues, en inhibant la croissance de la souche résistante aux antibiotiques. La composition antimicrobienne selon l'invention inhibe la croissance des bacilles gram négatifs et des bacilles gram positifs résistants aux antibiotiques bêta-lactames tels que la vancomycine, la pénicilline, la méthicilline et analogues ou résistants aux antibiotiques non bêta-lactames; elle peut, par conséquent, être utilisée dans la prévention ou le traitement de diverses maladies infectieuses causées par des infections bactériennes résistantes aux antibiotiques et peut également être utilisée efficacement en tant qu'antibiotique contre les superbactéries.
PCT/KR2010/002845 2009-05-13 2010-05-04 Composition antimicrobienne active contre une souche résistante aux antibiotiques Ceased WO2010131865A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR1020090041757A KR101171871B1 (ko) 2009-05-13 2009-05-13 설포라펜을 유효성분으로 포함하는 항생제 내성 균주에 대한 항균용 조성물
KR10-2009-0041757 2009-05-13
KR10-2009-0041743 2009-05-13
KR1020090041743A KR20100122713A (ko) 2009-05-13 2009-05-13 설포라판을 유효성분으로 포함하는 항생제 내성 균주에 대한 항균용 조성물

Publications (2)

Publication Number Publication Date
WO2010131865A2 WO2010131865A2 (fr) 2010-11-18
WO2010131865A3 true WO2010131865A3 (fr) 2011-03-24

Family

ID=43085430

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/002845 Ceased WO2010131865A2 (fr) 2009-05-13 2010-05-04 Composition antimicrobienne active contre une souche résistante aux antibiotiques

Country Status (1)

Country Link
WO (1) WO2010131865A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111956651A (zh) * 2020-08-19 2020-11-20 陈洪亮 一种新型抗生素
CN115066416A (zh) * 2020-08-20 2022-09-16 普洱祺云生物科技有限公司 富含萝卜硫素的提取物的制备方法及用途
CN116077509B (zh) * 2023-02-07 2024-09-24 湖北省农业科学院畜牧兽医研究所 鹿蹄草素与磺胺异恶唑组合物及其在抑制细菌中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000086414A (ja) * 1998-09-04 2000-03-28 Kinjirushi Wasabi Kk 制菌、抗菌性に優れた抗菌剤

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000086414A (ja) * 1998-09-04 2000-03-28 Kinjirushi Wasabi Kk 制菌、抗菌性に優れた抗菌剤

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JED W. FAHEY ET AL.: "Sulforaphane inhibits extracellular, intracellular, and antibiotic- resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors", PNAS, vol. 99, no. 11, 28 May 2002 (2002-05-28), pages 7610 - 7615 *
NOELLE L JOHANSSON ET AL.: "Growth inhibition of a spectrum of bacterial and fungal pathogens by sulforaphane, an isothiocyanate product found in broccoli and other cruciferous vegetables", PLANTA MEDICA, vol. 74, no. 7, 2008, pages 747 - 750 *

Also Published As

Publication number Publication date
WO2010131865A2 (fr) 2010-11-18

Similar Documents

Publication Publication Date Title
BR112014027842A2 (pt) bacteriófago lisina e combinações de antibióticos contra bactérias gram-positivas
WO2018208985A3 (fr) Composés antibactériens
IL235526B2 (en) Prevention, disruption and treatment of biofilm with bacteriophage lysin
WO2009111064A3 (fr) Composés de minocycline et procédés d’utilisation de ceux-ci
NZ591051A (en) C7-fluoro substituted tetracycline compounds
JP2011529898A5 (fr)
WO2016049586A3 (fr) Antibiotiques autres que les bêta-lactamines
MX2021003084A (es) Compuestos antibacterianos.
WO2008126846A1 (fr) Agent antibactérien actif contre les bactéries à gram positif résistantes à la vancomycine
MX2011008043A (es) Derivados de actagardina.
Fan et al. Antibacterial activity of the recombinant antimicrobial peptide Ib-AMP4 from Impatiens balsamina and its synergy with other antimicrobial agents against drug resistant bacteria
MX2011007414A (es) Composicion farmaceutica para proteger a un animal contra un trastorno que se origina de una infeccion con una bacteria que pertenece al grupo de actinomicentos nacardioformes.
WO2010041970A3 (fr) Peptides de phage antibactériens et procédés d’utilisation de ceux-ci
WO2010131865A3 (fr) Composition antimicrobienne active contre une souche résistante aux antibiotiques
WO2013041663A3 (fr) Dérivés d'apidaecine utilisés comme peptides antibiotiques
WO2010123599A3 (fr) Compositions anti-bactériennes et procédés comprenant le ciblage de facteurs de virulence de staphylococcus aureus
MX2009006808A (es) Eliminacion e inhibicion del crecimiento del estafilococo aureus resistente a la meticilina mediante bacterias del acido lactico.
PL2297195T3 (pl) Peptydy przeciwbakteryjne
WO2007127218A3 (fr) Composé antimicrobien dérivé de streptomyces et procédé utilisant ce composé pour lutter contre des bactéries résistant aux antibiotiques
UA87548C2 (ru) Антибиотик 107891, его факторы а1 и а2, фармацевтически приемлемые соли и композиция и их применение
WO2009124086A3 (fr) Médicament antibactérien pour le traitement d’infections à staphylococcus aureus et d’autres bactéries gram positif
WO2007142725A3 (fr) Combinaison d'inhibiteurs de gyrase b et d'inhibiteurs de synthèse protéique, et utilisation de ladite combinaison
WO2013066469A3 (fr) Inhibiteurs de kinases capables de renforcer la sensibilité d'agents pathogènes bactériens aux antibiotiques de la famille des b-lactamines
MX2010014248A (es) Nuevos antibioticos de trinem e inhibidores de beta-lactamasas.
Anyanwu Assessment of the in vitro antibacterial activity of honey on some common human pathogens

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10775067

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10775067

Country of ref document: EP

Kind code of ref document: A2